LONDON, April 8, 2014 /PRNewswire/ --
The trading session on Monday, April 07,
2014 ended on a lower note as the Dow Jones Industrial
Average finished at 16,245.87, down 1.02% and the NASDAQ Composite
closed at 4,079.75, down 1.16%. The S&P 500 finished the
session 1.08% lower at 1,845.04. The losses were broad based as
nine out of ten sectors posted losses. Investor-Edge looks at some
of the equities which attracted the most attention and traded the
most shares during the session. These include Mallinckrodt PLC
(NYSE: MNK), American Eagle Outfitters Inc. (NYSE: AEO), Blackstone
Group L.P. (NYSE: BX) and Inovio Pharmaceuticals Inc. (NYSE MKT:
INO). Free technical research on MNK, AEO, BX and INO can be
downloaded upon signing up at:
http://www.investor-edge.com/915-register
Mallinckrodt PLC's shares recorded trading volume of 23.63 million
shares, against a three-month average volume of 1.13 million
shares. On Monday, the stock closed the day at $60.95, down 2.51% and with an intraday
fluctuation between $56.12 and
$65.27. Mallinckrodt PLC's shares have fallen by 2.87% in
the past three trading sessions and 10.54% in the last one month,
while the same has gained 16.63% on YTD basis. The S&P 500
Health Care Sector Index declined 2.85% in the previous three
trading sessions, while the S&P 500 fell by 2.43% during the
same period. The stock is trading below its 50-day moving average.
Mallinckrodt PLC's 50-day moving average of $65.01 is above its 200-day moving average of
$51.31. The stock has a Relative
Strength Index (RSI) of 38.64. Sign up today to read free research
on MNK at:
http://www.investor-edge.com/915-MNK-08Apr2014.pdf
Shares in American Eagle Outfitters Inc. recorded heavy trading
volume as a total of 12.82 million shares changed hands, against a
three-month average volume of 5.72 million shares. On Monday, the
stock finished the day at $11.68,
down 7.89% and at an intraday range of $11.60 and $12.42.
The company's shares traded at a PE ratio of 15.86. American Eagle
Outfitters Inc.'s shares have declined 8.18% in the previous three
trading sessions, 18.78% in the last one month and 18.89% on YTD
basis. The S&P 500 Consumer Discretionary Sector Index mapped a
loss of 4.42% in the previous three months, while the S&P 500
gained 0.39% during the same period. The stock is trading below its
50-day and 200-day moving averages of $13.39 and $15.20,
respectively. The company's shares have an RSI of 43.74. Sign up
today to read free research on AEO at:
http://www.investor-edge.com/915-AEO-08Apr2014.pdf
On Monday, Blackstone Group L.P.'s shares recorded heavy trading
volume as a total of 12.24 million shares changed hands, as
compared with its three-month average volume of 5.16 million
shares. The stock traded at an intraday trading range of
$30.86 and $32.71, before closing the day at $31.17, down 4.97%. The company's shares traded
at a PE ratio of 10.12. Blackstone Group L.P.'s shares have lost
6.51% in the past three trading sessions, 10.35% in the last one
month and 1.05% on YTD basis. The S&P 500 Financials Sector
Index mapped a loss of 2.18% in the previous one month, while the
S&P 500 declined 1.76% during the same period. The stock is
trading below its 50-day moving average. Blackstone Group L.P.'s
50-day moving average of $32.68 is
above its 200-day moving average of $27.44. The company's shares have an RSI of
47.02. Sign up today to read free research on BX at:
http://www.investor-edge.com/915-BX-08Apr2014.pdf
Shares in Inovio Pharmaceuticals Inc. recorded heavy trading volume
as a total of 9.94 million shares changed hands on Monday, as
compared with its three-month average volume of 7.59 million
shares. The stock ended the day at $2.96, down 5.73% and at an intraday range of
$2.88 and $3.12. The company's shares have fallen by 14.70%
in the previous three trading sessions and 12.94% in the last one
month, while the same have gained 2.07% on YTD basis. The S&P
500 Health Care Sector Index gained 3.19% in the previous three
months, while the S&P 500 advanced 0.39% during the same
period. The company's shares are trading below its 50-day
moving average. Inovio Pharmaceuticals Inc.'s 50-day moving average
of $3.16 is above its 200-day moving
average of $2.23. The stock has an
RSI of 44.12. Sign up today to read free research on INO at:
http://www.investor-edge.com/915-INO-08Apr2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a
best efforts basis and reviewed by Namrata
Maheshwari, a CFA charterholder. However, we are only human
and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
3. This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at
compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage
on your company? Send us a full investors' package to research [at]
http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis.
This document, article or report is prepared and authored by
Investor-edge. An outsourced research services provider represented
by Namrata Maheshwari, CFA, has only
reviewed the information provided by Investor-edge in this article
or report according to the Procedures outlined by Investor-edge.
Investor-edge is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the
articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or
otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Investor-edge
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Investor-edge expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Investor-Edge